Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneTina Green, Michael Møller, Attilio Orazi et al.|Journal of Clinical Oncology|2012Cited by 682
Clonal Hematopoiesis Mutations and Cell-Free DNA Characteristics in Patients with High-Risk Large B-Cell LymphomasMiro Nylén, Mikko Myllymäki, Leo Meriranta et al.|Blood|2024Cited by 0